Pretreatment with JNK inhibitor SP600125 diminishes the phosphorylation of JNK3 and c-Jun, and further inhibits the activation of caspase-3 after cerebral ischemia/reperfusion (Shao et al., 2017). The gene discussed is MAPK10; the disease is Cerebral ischemia.